Myasthenic sera recognize the human acetylcholine receptor bound to thymopoietin.
The thymic hormone, thymopoietin (Tpo), from human (HTpo), bovine (BTpo) and from synthetic (sHTpo) origins bound to the acetylcholine receptor (AChR) solubilized by Triton 1.5% from human muscle. This binding was demonstrated either by inhibition of formation of radiolabeled alpha bungarotoxin (alpha Bgt)-AChR complexes measured after precipitation by ammonium sulfate or by a myasthenic serum containing a high concentration of anti-AChR antibodies, or directly by incubating the human AChR with radiolabeled sHTpo or BTpo. The 125I-labeled alpha Bgt-AChR complexes were totally inhibited by 10(-6) M sHTpo or BTpo. The complexes formed by AChR and the radiolabeled Tpo were recognized specifically by sera containing anti-AChR antibodies from myasthenic patients. The active pentapeptide derivative of Tpo, thymopentin, another thymic hormone, thymulin, as well as bovine insulin did not interfere with the specific binding of alpha Bgt to human AChR. Tpo and anti-AChR antibodies could participate together in the inhibition of neuromuscular conduction with Tpo modulating the depressive effect of the antibodies on the neuromuscular junction in myasthenia gravis.
D001323:Autoantibodies / Q000276:immunology*; D002038:Bungarotoxins / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D046911:Macromolecular Substances; D009157:Myasthenia Gravis / Q000276:immunology*; D011485:Protein Binding; D011978:Receptors, Nicotinic / Q000276:immunology*; D013946:Thymopoietins / Q000276:immunology*; D013951:Thymus Hormones / Q000276:immunology*
D001323:Autoantibodies; D002038:Bungarotoxins; D046911:Macromolecular Substances; D011978:Receptors, Nicotinic; D013946:Thymopoietins; D013951:Thymus Hormones